Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo-controlled, double-blind, dose-escalation study

Genetic associations in type I interferon related pathways with autoimmunity

(2012) Angélica M Delgado-Vega et al.   ARTHRITIS RESEARCH & THERAPY

Cytokines as therapeutic targets in SLE

(2010) Lars Rönnblom et al.   Nature Reviews Rheumatology

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study

(2009) Jason W. Bauer et al.   ARTHRITIS AND RHEUMATISM

Review of recent genome-wide association scans in lupus

(2009) R. R. Graham et al.   JOURNAL OF INTERNAL MEDICINE

Interferon-induced versus chemokine transcripts as lupus biomarkers

(2009) Mary K Crow et al.   ARTHRITIS RESEARCH & THERAPY

Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients

(2008) Timothy B. Niewold et al.   ARTHRITIS AND RHEUMATISM

Critical role for constitutive type I interferon signaling in the prevention of cellular transformation

(2008) Hui-min Chen et al.   CANCER SCIENCE